Evaluation of a single injection of a sustained-release formulation of moxidectin for prevention of experimental heartworm infection after 12 months in dogs

American Journal of Veterinary Research

Volumn 65, Issue 11, 2004, Pages 1596-1599

  Holm Martin, Merete ^a   Atwell, Rick ^b  

^a Fort Dodge Australia Pty Ltd   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MOXIDECTIN;

AGE; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CONTROLLED STUDY; DIROFILARIA IMMITIS; DOG DISEASE; DRUG EFFICACY; DRUG INFUSION; ENDEMIC DISEASE; EXPERIMENTAL ANIMAL; FEMALE; INOCULATION; LARVAL STAGE; MALE; NONHUMAN; SUSTAINED RELEASE FORMULATION;

AEDES; ANIMALS; ANTINEMATODAL AGENTS; AUSTRALIA; DELAYED-ACTION PREPARATIONS; DIROFILARIASIS; DOG DISEASES; DOGS; DRUG EVALUATION; MACROLIDES;

ANIMALIA; CANIS FAMILIARIS; DIROFILARIA IMMITIS;

EID: 9444285500     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1596     Document Type: Article

References (13)

1. Otto GF. Changing geographic distribution of heartworm disease in the United States, in Proceedings. 1st Triennial Symp Am Heartworm Soc 1974;1-2.
2. Walters LL. Risk factors for heartworm infection in Northern California, in Proceedings. 8th Triennial Symp Am Heartworm Soc 1995;5-26.
3. Carlisle CH, Atwell RB. A survey of heartworm in dogs in Australia. Aust Vet J 1984;61:356-360.
4. Pacheco G. Synopsis of Dr. Seiji Kume's reports at the first international symposium on canine heartworm disease, in Proceedings 1st Triennial Symp Am Heartworm Soc 1974;137-139.
5. McCall JW, McTier TL, Holmes RA, et al. Prevention of naturally acquired heartworm infection in heartworm-naïve beagles by oral administration of moxidectin at an interval of either one or two months, in Proceedings. 7th Triennial Symp Am Heartworm Soc 1992;169-177.
6. McTier TL, McCall JW, Dzimianski MT, et al. Prevention of experimental heartworm infection in dogs with single oral doses of moxidectin, in Proceedings. 7th Triennial Symp Am Heartworm Soc 1992; 165-168.
7. Lok JB, Knight DH, Wang GT, et al. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. AmJ Vet Res 2001;62:1721-1726.
8. Orihel TC. Morphology of the larval stages of Dirofilaria immitis in the dog. J Parasitol 1961;47:251-262.
9. Lok JB. Dirofilaria sp: taxonomy and distribution. In: Boreham PFL, Atwell RB, eds. Dirofilariasis. Boca Raton, Fla: CRC Press Inc, 1988; 1-28.
10. Whelan PI, Jacups SP, Melville L, et al. Rainfall and vector mosquito numbers as risk indicators for mosquito-born disease in central Australia. Commun Dis Intell 2003;27:110-116.
11. Russell RC. Mosquito-borne arboviruses in Australia: the current scene and implications of climate change for human health. Int J Parasitol 1998;28:955-969.
12. Kelly-Hope LA, Purdie DM, Kay BH. Ross River virus disease in Australia, 1986-1998, with analysis of risk factors associated with outbreaks. J Med Entomol 2004;41:133-150.
13. Zwijnenberg R. Fort Dodge Pty. Limited Adverse Reaction Database; Accessed 2002.